z-logo
open-access-imgOpen Access
SVZ-nested GBM-initiating cells are resistant to radiotherapy treatment, due to mesenchymal activation by SVZ-released CXCL12.
Author(s) -
Arnaud Lombard,
Nicolas Goffart,
Matthias Dedobbeleer,
Estelle Willems,
Martin Didier,
Bernard Rogister
Publication year - 2016
Publication title -
frontiers in aging neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.827
H-Index - 78
ISSN - 1663-4365
DOI - 10.3389/conf.fnagi.2016.03.00091
Subject(s) - mesenchymal stem cell , radiation therapy , chemistry , cancer research , medicine , neuroscience , psychology , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom